ALS Nexus 2026: Event spotlights care advances, community goals

When I was diagnosed with ALS, my first thought wasn’t about me. It was about my children. I’m a mother of six; one of my children has passed away, and today my family and I are building a new life in New York after moving from Puerto Rico. I wondered how I would…

People with amyotrophic lateral sclerosis (ALS) who are exposed to high levels of certain pollutants in the years before disease onset have worse survival outcomes, a new study shows. The findings add to building evidence that pollution and environmental toxins can affect the course of ALS. Researchers are calling…

A buildup of microplastics in the nervous system may be linked to a higher risk of developing amyotrophic lateral sclerosis (ALS), according to a new study. People newly diagnosed with the neurodegenerative disease were found to have higher concentrations of tiny plastic particles in both their blood and the…

A newer set of diagnostic criteria for amyotrophic lateral sclerosis (ALS) was significantly more sensitive at identifying people with the disease than two older diagnostic approaches, a real-world study in Germany found. Among more than 400 people ultimately diagnosed with ALS, these Gold Coast criteria correctly identified 92.5% of…

The challenges of caregiving have been in the news lately. Last year, Dolly Parton appeared in a video following the death of her husband, Carl Dean, to quell rumors about her own poor health after the cancellation of some shows. She said, “Back when my husband, Carl, was very sick,…

Neurosense Therapeutics is revamping its development plan for PrimeC, the company’s experimental oral therapy for amyotrophic lateral sclerosis (ALS). The updated plan includes a new study that will directly compare PrimeC against an approved ALS treatment, as well as a restructured Phase 3 trial and analyses of…

A few months ago, my husband and I decided it was time to replace the mattress set we’d slept on for the past 10 years. Though originally high-quality, its firmness had faded to the point that our bodies left two permanent troughs where we snoozed each night. Who knew a…

BTT Medical Institute is launching an early-stage clinical trial to test the safety of the Abreu BTT 700 Temperature Management System — a device that slowly raises body temperature to induce a controlled fever — with the goal of developing it as a possible treatment for amyotrophic lateral…

The U.S. Food and Drug Administration (FDA) has granted fast-track designation to CK0803, an experimental T-cell therapy from Cellenkos that’s currently in Phase 1 clinical testing for people with amyotrophic lateral sclerosis (ALS). The designation aims to accelerate the clinical development and regulatory review of new treatments that…